Loading...
Loading...
Loading...
Offical Journal of the Punjab Institute of Cardiology, Lahore-Pakistan

editorincharge@jcvdpic.org

+092-42-99203207

Plagiarism and Duplicate Publication Policy

The Journal of Cardiovascular Diseases (JCVD) is committed to publishing original work and maintaining the integrity of the scientific record. This policy applies to all manuscripts submitted to, accepted by, or published in the journal. JCVD considers relevant guidance from the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Higher Education Commission (HEC), Pakistan, when addressing plagiarism and overlapping publication.

Plagiarism and overlapping work

Plagiarism is the presentation of another person’s words, ideas, data, images, or other work as one’s own without appropriate acknowledgement. It includes copying text without attribution, close paraphrasing without citation, and using another person’s research material without proper credit.
JCVD also considers undisclosed reuse of an author’s own published work. This may include duplicate or redundant publication, substantial text recycling, and salami slicing dividing substantially overlapping findings into separate papers without adequate disclosure or justification. Reuse is assessed in context: appropriate citation and disclosure may be necessary, but they do not automatically make a substantially duplicate publication acceptable.

Use of Artificial Intelligence

The Journal only allows the responsible use of artificial intelligence with human insight and with full author responsibility.

  • AI can help in assistance like grammatical corrections, readability and presentation.
  • Authors must review and edit all output. They must verify the facts against original sources, checking for errors and fabrication.
  • AI output is not an authoritative source of scientific evidence.
  • AI used for analysis, modelling, image processing, or other research tasks must be described in the Methods section. Report the tool, developer, version where available, purpose, relevant inputs and settings.
  • AI must not fabricate data, results and references.
  • Synthetic data or simulations must be justified and clearly identified.
  • AI-generated illustrations and graphical abstracts must be accurate and disclosed in figure legends and in the AI declaration.
  • AI must not create or alter ECGs, echocardiograms, angiograms, photographs, or other images presented as genuine clinical evidence.
  • AI cannot be an author or co-author.
  • All authors must review and approve the final manuscript and accept responsibility for its accuracy, originality, integrity and AI-assisted content.
  • Mandatory disclosure of AI use in the covering letter and a “Declaration of AI and AI-Assisted Technologies” before the references.
  • Routine use of AI, like spelling checks, reference formatting and basic grammatical correction, needs no disclosure.
  • AI-generated, substantially written, or summarized content must be disclosed.
  • The authors will accept full responsibility for the final manuscript.
  • If no AI was used, the author must give an undertaking: “No generative AI or AI-assisted technologies were used in preparing this manuscript.”
  • Authors must not upload any identifiable patient data to an AI platform without written consent of the patient and authorization from the institution.
  • Reviewers are strictly prohibited from uploading any review material to any AI platform, in order to safeguard confidentiality.
  • Use of AI must not replace independent review and editorial decision.
  • Undisclosed use of AI may lead to rejection or retraction of the manuscript at any stage of the publication process.
  • Detection of AI will not by itself lead to rejection, but the author will have an opportunity to explain their position before a final decision.
Authors’ responsibilities

Authors must ensure that their manuscript is original, that all sources are properly cited, and that any reproduced material is used with the necessary permission. They must disclose related publications, preprints, and manuscripts under consideration elsewhere in the cover letter, and provide copies if requested by the editors.
The same manuscript must not be submitted simultaneously to more than one journal, including in different languages. Work based on a thesis may be considered, provided that the thesis and related publications are disclosed and the submitted manuscript offers an appropriate original contribution. Authors remain responsible for understanding and complying with these requirements; lack of awareness is not an excuse for plagiarism or undisclosed overlap.

Similarity screening
Turnitin Result Editorial Action
19% or less overall The manuscript may proceed, subject to review of significant matches. A match of 5% or more from a single source without citation must be addressed.
More than 19% and upto 40% overall The manuscript will normally be returned to the authors with similarity report for explanation appropriate revesion before furhter consideration.
More than 40% overall Processing will be paused for editorial assessment. The manuscript may be returned for explanation or rejected, depending on the nature of the overlap.

These are JCVD’s editorial screening thresholds, not automatic definitions of plagiarism. A manuscript below a threshold may still contain plagiarism, and one above a threshold is not automatically plagiarized. The single source provision reflects HEC’s guidance that a match of 5% or more without citation requires revision.

Assessment and decisions

If plagiarism or substantial undisclosed overlap is suspected at any stage, JCVD will pause further processing or publication while the matter is assessed. The editorial committee comprising the Editor-in-Chief, Managing Editor, and relevant Associate or Assistant Editors will review the evidence. The corresponding author will be asked to provide an explanation and any supporting documents within 30 days of receiving the journal’s notice.
The committee will consider the extent and significance of the overlap, the authors’ explanation, and applicable COPE guidance before reaching a decision. If the explanation is satisfactory and the issue can be corrected, the journal may request revisions and resume editorial or peer review. If serious plagiarism is confirmed, the manuscript will be rejected. Failure to respond, or an unsatisfactory response, will be considered alongside the available evidence; it will not replace an assessment of that evidence.
Where justified by the findings, JCVD may refer the matter to the authors’ institution or an appropriate professional or regulatory body. The journal may also impose a proportionate restriction on future submissions following a documented editorial decision. If simultaneous submission is established, JCVD may inform the other journal’s editor as appropriate. Such actions will not be based on a similarity score alone.

Concerns after publication

JCVD will investigate credible allegations concerning published articles and invite the authors to respond. Depending on the findings, the journal may publish a correction, an expression of concern while a significant issue remains unresolved, or a retraction. Limited unattributed material may be addressed by a correction; serious plagiarism or redundant publication may warrant retraction. A retraction notice will explain the reason and remain linked to the article so that the publication record is clear.

Reporting concerns

Readers, reviewers, and authors may report suspected plagiarism or overlapping publication to editorincharge@jcvdpic.org. A report should identify the manuscript or article, the source of the suspected overlap, and the material at issue. Claims of theft of ideas or data should include any available documentary evidence. JCVD will assess reports fairly and handle them confidentially as far as practicable.





Get In Touch

2nd Floor Conference Room, Punjab Institute of Cardiology, Lahore

editorincharge@jcvdpic.org

+092 042-99203207

© www.jcvdpic.org. All Rights Reserved.